Your browser doesn't support javascript.
loading
Efficacy and safety of alemtuzumab in Korean multiple sclerosis patients.
Kim, Hyunjin; Lee, Eun-Jae; Kim, Sung Keun; Kim, Kwang-Kuk; Lim, Young-Min.
Afiliação
  • Kim H; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.
  • Lee EJ; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.
  • Kim SK; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.
  • Kim KK; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea.
  • Lim YM; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea. Electronic address: limy@amc.seoul.kr.
Mult Scler Relat Disord ; 30: 247-251, 2019 May.
Article em En | MEDLINE | ID: mdl-30849681

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alemtuzumab / Antineoplásicos Imunológicos / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alemtuzumab / Antineoplásicos Imunológicos / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2019 Tipo de documento: Article